Go Back

Report Abuse

ASIANFUNDFORCANCERRESEARCHLIMITEDLOGO.jpeg

Asian Fund For Cancer Research Limited

Description

The Asian Fund for Cancer Research Limited (AFCR) is committed to fund cancer research, especially those cancers prevalent in Asian populations, and promote global collaborations for high impact to save the lives of cancer patients.

We believe that research holds the key that may end cancer. That’s why at AFCR, we place the highest priority in advancing cutting-edge cancer research in all important fields that will lead to better preventative methods, advanced diagnostic tools, more effective treatment approaches. We fund projects in a variety of important research fields, such as overcoming cancer’s resistance to chemotherapy, developing new screening tests for early detection, optimizing approaches of personalized medicine, and stopping cancer metastasis, etc.

AFCR provides the public with a wide variety of in-depth, user-friendly cancer prevention information and healthy lifestyle suggestions. We help the community understand the latest scientific achievements and their potential significance to improve the prevention, diagnosis and treatment of cancer. Armed with this knowledge, people can better protect themselves against cancer.

Official Government Information

Chinese Name
亞洲癌症研究基金會有限公司
Effective date
September 9, 2005
Org. Structure
Company limited by guarantee under the Companies Ordinance

Contact Information

Phone
Address
Room 2914, Hong Kong Plaza, 188 Connaught Road West, Hong Kong Central, Hong Kong 999077, HK

Additional Information

Target Beneficiaries
Other Chronic Illnesses, Physically Disabled
Sustainable Development Goals
SDG3: Good Health and Well-being

Directors

Financial & Legal Information

Working Capital Ratio
8.82
Donation Received
$3,449,203
Subvention Funding from SWD
$0
Total Income
$3,381,897
Total Expenditure
$4,339,688
Surplus/Deficit
-$957,791
Latest Audit: Financial Year End Date
December 31, 2020
Balance Carried Forward to Next Year
$46,388,684
Total Assets
$46,522,379
Total Liabilities
$133,695
Director Remuneration
$0
Liabilities to Assets Ratio
0.29%

Social Media

Transparency

Audit on website?
No
Annual report on website?
No
Directors disclosed on website?
No

There are no reviews yet.

Leave a Review

Your email address will not be published. Required fields are marked *

Feedback Form

Last Updated By

Jon Pedersen

Member since 4 years ago
View Profile